Found 14 matching trials
Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
PHASE4This study will test the effectiveness of two different treatments for chil...
Location
University of Maryland
DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics
N/AThe purpose of this study is to assess patients treated with the antipsycho...
Location
Hartford Hospital Institute of Living
Reducing the Abuse Liability of Prescription Opioids
EARLY_PHASE1Opioid (commonly called narcotic) pain medicines are, after marijuana, the ...
Location
Westgate Pain Clinic
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
PHASE3The long-term objective of the MIND-USA (Modifying the Impact of ICU-Induce...
Location
Denver Health/University of Colorado Health Sciences Center
Gene-by-Stress Interactions in Intervention Studies Significance
PHASE1The purpose of this study is to identify gene variants that increase risk o...
Location
Duke University Medical Center
The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia
NAA randomized, double-blind trial of the treatment effect of dose-low antips...
Location
Multiple Locations
Antipsychotic Induced Structural and Functional Brain Changes
PHASE4Continuation of antipsychotic drug treatment for at least 12 months after r...
Location
RWTH University Hospital Aachen
Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia
PHASE1Schizophrenia is a severe psychotic illness of unknown cause that affects 1...
Status
Active Not Recruiting
Location
Banner University Medical Center
Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)
PHASE4Psychotropic-related weight gain is a common concern among patients with bi...
Location
University Hospitals Case Medical Center
Elpipodect (MK-8189) Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003)
PHASE1This 3-part dose titration study will assess elpipodect safety, tolerabilit...
Location
Multiple Locations